Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic Differences in Propofol Safety Endpoints in Children
NCT04164264Phase 4Active, not recruiting
- Sponsor
- University of British Columbia
- Start
- Mar 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol injection (veterinary) in Anesthesia, sponsored by University of British Columbia. Primary endpoints: Dose of propofol required to produce loss of consciousness and Dose of propofol required to produce apnea. Started Mar 2020; status: active, not recruiting.
02
Drugs
propofol injection (veterinary)
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT04164264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04164264.